DiabetesMine D-Data is an extraordinary semi-annual event that showcases significant and unique topics in diabetes technology and management, hosted by founder/T1D Amy Tenderich. This year’s virtual was, as always, informative, educational, and exciting to...
New potential diabetes treatment regenerates insulin-producing cells was written by Michael Irving for NewAtlas.com, 13 June 2022. An emerging way to treat diabetes is to repair or replace the cells in the body that naturally produce insulin. Swedish researchers have...
FTC votes unanimously to increase scrutiny over pharmacy agent fees was reported by Dulan Lokuwithana for SeekingAlpha.com, 16 June 2022. The Federal Trade Commission (FTC) voted unanimously to adopt a policy statement stating its intention to more closely examine the...
Dexcom and Abbott’s fight over glucose monitoring patents intensifies in Europe was posted by Amy Sandys for Juve-Patent.com, 20 May 2022. Dexcom and Abbott are currently going head-to-head over twelve separate patents covering their respective glucose monitoring...
More on Dexcom: Dexcom CEO Sayer on G7 FDA submission, developing a 15-day sensor, M&A plans was published by Ricky Zipp for MedTechDive.com, 7 June 2022. The executive spoke about the company’s discussions with the FDA on the G7 CGM system,...
ABBOTT NEWS US FDA approves Abbott’s FreeStyle Libre 3 system for diabetic patients was reported by MedicalDevice-Network.com, 1 June 2022. The US Food and Drug Administration (FDA) has granted clearance to Abbott’s next-generation FreeStyle...
How a Dexcom-Insulet combination would shake up the diabetes treatment industry was published by Ricky Zipp for MedTechDive.com, 25 May 2022. After last year’s barrage of deal-making in the medical device industry, there have been few acquisitions in...
OPEN LETTER to: • Robert M. Califf, M.D., Commissioner of Food & Drugs, USFDA • Jeffrey E. Shuren, M.D., J.D. Director, Ctr for Devices & Radiological Health, US FDA • Kellie Kelm, Ph.D, Director, Office of Health Technology 7, US FDA • Yiduo Wu, Ph.D., Branch...
WOW, BIG NEWS!!! Dexcom Is in Talks to Acquire Device Firm Insulet was reported by Ed Hammond and Michelle F. Davis for Yahoo.com/Finance, 23 May 2022. Dexcom Inc. is in talks to acquire medical-device company Insulet Corp. in a deal that would create a giant in...
Evotec, Sernova Striving for Functional Diabetes Cure was published by Alex Keown for BioSpace.com, 17 May 2022. Two life sciences powerhouses are coming together to develop an off-the-shelf beta cell replacement therapy for insulin-dependent diabetes patients,...